Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, December 9, 2026, 12 PM-1 PM ET
Hear an expert pathologist discuss the role of HER2 IHC testing and scoring in solid tumors including endometrial, ovarian, cervical, bladder, non-small cell lung, colorectal, and biliary cancers
Webinar presenter Michelle Shiller, DO, MSPT, Baylor Sammons Cancer Center; Fulgent Genetics; Texas Cancer Interception Institute
CAP TODAY does not endorse any of the products or services named within. This program is intended for US healthcare professionals. This program is being sponsored by AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
A funny thing happened to me on my way to the office a few months back. After many years in the thought and planning process our anatomic pathology laboratory with one of our hospital partners is being renovated. As part of the renovation, temporary workspaces and relocation of equipment and personnel is needed. [more] More CAP TODAY Recommends
Cortex and Zirmed offer a free webinar entitled “Five ways to get paid faster.” In this webinar, Julie Millican, billing supervisor at Trumbull Laboratories, will discuss how she reduced accounts receivable by 55 percent, achieved a 98 percent claims first-pass yield rate, submits claims faster within online claims editing tools, and more. The webinar is offered twice, once on Tuesday, March 12, and again on Thursday, March 14. [more] More CAP TODAY Recommends
Sequenom offers free webinars on its iPlex Pro Sample ID Panel and its Assay Design Suite 1.0 software. The iPlex webinar is on Wednesday, Feb. 27, while the Assay Design Suite webinar is on Thursday, March 7. Register here. More CAP TODAY Recommends
Agilent Genomics offers a free eSeminar on comprehensive next-generation sequencing solutions. The eSeminar is on Thursday, March 28 at 11 a.m. EST. The eSeminar will feature Agilent Next Generation Sequencing Solutions for Gene Regulation, a presentation by Yong Yi, the company’s associate NGS marketing director, and Simplify the Sequencing of Clinical Research Samples, a presentation by Olle Ericsson, the company’s NGS marketing director. Register for the seminar here. More CAP TODAY Recommends
